质子泵抑制剂的长期影响综述
Review of the Long-Term Effects of Proton Pump Inhibitors.
作者信息
Lehault William B, Hughes David M
机构信息
is chief pharmacist for the U.S. Bureau of Prisons Federal Correctional Institute Otisville in New York. is a first year resident at the University of California, San Francisco Medical Center in California.
出版信息
Fed Pract. 2017 Feb;34(2):19-23.
Abstract
Proton pump inhibitors are widely used, but up to 70% of patients take them without an appropriate indication and face risk of adverse effects associated with long-term use.
摘要
质子泵抑制剂被广泛使用，但高达70%的患者在没有适当指征的情况下服用它们，并面临与长期使用相关的不良反应风险。
相似文献
1
Review of the Long-Term Effects of Proton Pump Inhibitors.质子泵抑制剂的长期影响综述
Fed Pract. 2017 Feb;34(2):19-23.
2
Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.综述文章：质子泵抑制剂长期抑酸治疗的潜在胃肠道影响
Aliment Pharmacol Ther. 2000 Jun;14(6):651-68. doi: 10.1046/j.1365-2036.2000.00768.x.
3
Review article: the long-term use of proton-pump inhibitors.综述文章：质子泵抑制剂的长期使用
Aliment Pharmacol Ther. 2005 Aug;22 Suppl 1:55-63. doi: 10.1111/j.1365-2036.2005.02611.x.
4
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?瑞士一家三级保健医院质子泵抑制剂处方快照：少即是多？
Int J Clin Pharm. 2019 Dec;41(6):1634-1641. doi: 10.1007/s11096-019-00929-w. Epub 2019 Oct 29.
5
Adverse effects of proton pump inhibitors: fact or fake news?质子泵抑制剂的不良反应：事实还是假新闻？
Curr Opin Gastroenterol. 2018 Nov;34(6):451-457. doi: 10.1097/MOG.0000000000000471.
6
Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?个人评论：是危言耸听还是对长期抑制胃酸分泌的合理担忧？
Aliment Pharmacol Ther. 2000 Mar;14(3):267-71. doi: 10.1046/j.1365-2036.2000.00750.x.
7
Persistence and adherence to proton pump inhibitors in daily clinical practice.日常临床实践中质子泵抑制剂的持续性和依从性
Aliment Pharmacol Ther. 2006 Jul 15;24(2):377-85. doi: 10.1111/j.1365-2036.2006.02982.x.
8
[Adverse effects of long-term proton-pump inhibitor therapy on adults].长期质子泵抑制剂治疗对成年人的不良反应
Orv Hetil. 2018 May;159(19):735-740. doi: 10.1556/650.2018.31057.
9
[Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].[长期质子泵抑制剂治疗与骨质疏松症。真的存在风险吗？]
Orv Hetil. 2013 Jun 30;154(26):1005-9. doi: 10.1556/OH.2013.29656.
10
Safety profile of the proton-pump inhibitors.质子泵抑制剂的安全性概况。
Am J Health Syst Pharm. 1999 Dec 1;56(23 Suppl 4):S11-7. doi: 10.1093/ajhp/56.suppl_4.S11.
引用本文的文献
1
Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors.质子泵抑制剂的药效学、药代动力学、与其他药物的相互作用、毒性及临床疗效。
Front Pharmacol. 2025 Jul 23;16:1507812. doi: 10.3389/fphar.2025.1507812. eCollection 2025.
2
Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in Jordan.约旦社区药剂师对质子泵抑制剂使用的实践与知识：一项横断面研究
BMJ Open. 2025 Feb 8;15(2):e085589. doi: 10.1136/bmjopen-2024-085589.
3
Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.老年人急性冠状动脉综合征的管理：全面综述与基于多学科实践的建议。
J Clin Med. 2024 Jul 28;13(15):4416. doi: 10.3390/jcm13154416.
4
Consumption of proton pump inhibitors in outpatients of Gastroenterology Clinics in Khyber Pakhtunkhwa: evidence of inexpedient use.开伯尔-普赫图赫瓦省胃肠病学门诊患者中质子泵抑制剂的使用情况：不当使用的证据
Prz Gastroenterol. 2024;19(2):159-164. doi: 10.5114/pg.2024.139429. Epub 2024 May 8.
5
Navigating reflux disease after achalasia treatments: Balancing risks and benefits.治疗贲门失弛缓症后胃食管反流病的管理：权衡风险和获益。
World J Gastroenterol. 2024 Jun 7;30(21):2740-2743. doi: 10.3748/wjg.v30.i21.2740.
本文引用的文献
1
Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.质子泵抑制剂所致低镁血症：当前研究及提出的机制
World J Nephrol. 2016 Mar 6;5(2):152-7. doi: 10.5527/wjn.v5.i2.152.
2
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.质子泵抑制剂与痴呆风险的关联：基于药物流行病学索赔数据分析。
JAMA Neurol. 2016 Apr;73(4):410-6. doi: 10.1001/jamaneurol.2015.4791.
3
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.质子泵抑制剂的使用与慢性肾脏病风险
JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193.
4
Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.质子泵抑制剂与老年患者急性肾损伤风险：一项基于人群的队列研究。
CMAJ Open. 2015 Apr 2;3(2):E166-71. doi: 10.9778/cmajo.20140074. eCollection 2015 Apr-Jun.
5
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
6
Strategies for discontinuation of proton pump inhibitors: a systematic review.质子泵抑制剂停用策略：一项系统评价。
Fam Pract. 2014 Dec;31(6):625-30. doi: 10.1093/fampra/cmu050. Epub 2014 Sep 5.
7
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.慢性肾脏病和终末期肾病患者药物治疗的安全性。
Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13. doi: 10.1097/01.mnh.0000444912.40418.45.
8
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use.一项全国性巢式病例对照研究表明，使用质子泵抑制剂会增加急性间质性肾炎的风险。
Kidney Int. 2014 Oct;86(4):837-44. doi: 10.1038/ki.2014.74. Epub 2014 Mar 19.
9
Vitamin B12 and cognitive function: an evidence-based analysis.维生素B12与认知功能：基于证据的分析
Ont Health Technol Assess Ser. 2013 Nov 1;13(23):1-45. eCollection 2013.
10
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.质子泵抑制剂和组胺 2 受体拮抗剂的使用与维生素 B12 缺乏。
JAMA. 2013 Dec 11;310(22):2435-42. doi: 10.1001/jama.2013.280490.
Zotero 插件